The Pharmaceutical Research and Manufacturers of America (PhRMA) has just adopted important revisions to its PhRMA Code on Interactions with Healthcare Professionals. The newly revised PhRMA Code, which builds on the previous 2002 version, and its likely impact on drug marketing, will be examined during this audio conference.
WilmerHale partner Scott Lassman will be a featured speaker for this audioconference.
Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.
Thank you for your interest in WilmerHale.
